DC Chemicals

All products / DC31417

BVD-523 hydrochloride
CAT. NO. DC31417

BVD-523 hydrochloride

Pack sizes and prices

Pack sizePrice
100 mg$500 USDRequest a quote / confirm availability →
250 mg$800 USDRequest a quote / confirm availability →
1g$1,600 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

Ulixertinib, also known as BVD-523 and VRT752271, is an inhibitors of ERK protein kinase. Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis. Upon oral administration, BVD-523 inhibits both ERK 1 and 2, thereby preventing the activation of ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is often upregulated in a variety of tumor cell types and plays a key role in tumor cell proliferation, differentiation and survival.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC31417
Product nameBVD-523 hydrochloride
CAS1956366-10-1
Molecular formulaC21H23Cl3N4O2
Molecular weight469.792
Purity98%
SMILESCC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1.Cl

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — BVD-523 hydrochloride (DC31417)

Related research products

Browse newly added products